Table of contents

Letters

• Authors’ reply (21 October, 2008)

  S Kugathasan, L J Saubermann, L Smith, D Kou, J Itoh, D G Binion, A D Levine, R S Blumberg, C Fiocchi
• Small bowel cancer risk in Lynch syndrome (26 March, 2008)

  K Schulmann, C Engel, P Propping, W Schmiegel
• The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs (21 October, 2008)

  E Nguyen-Khac, D Capron, A Braillon, J L Dupas
• Authors’ response (21 October, 2008)

  M Fraquelli, C Rigamonti, M Colombo
• Ischaemia–reperfusion injury in non-alcoholic steatohepatitis (NASH) liver: a tough problem to cope with (21 October, 2008)

  C Xu, C Yu, Y Li
• Bevacizumab-based therapy for advanced small bowel adenocarcinoma (21 October, 2008)

  H Tsang, T Yau, P L Khong, R J Epstein
• Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis (21 October, 2008)

  M-H Zheng, H H-X Xia, Y-P Chen
• Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn’s disease patients eligible for anti-α4 integrin therapy? (21 October, 2008)

  G Pineton de Chambrun, G Vernier-Massouille, N Viget, J-F Colombel, Y Yazdanpanah
• Authors’ response (21 October, 2008)

  G Van Assche, J Verbeeck, S Vermeire, M Van Ranst, P Rutgeerts